JAK2 inhibition has different therapeutic effects according to myeloproliferative neoplasm development in mice

JAK2 inhibition therapy is used to treat patients suffering from myeloproliferative neoplasms (MPN). Conflicting data on this therapy are reported possibly linked to the types of inhibitors or disease type. Therefore, we decided to compare in mice the effect of a JAK2 inhibitor, Fedratinib, in MPN m...

Descripción completa

Detalles Bibliográficos
Autores principales: Debeurme, Franck, Lacout, Catherine, Moratal, Claudine, Bagley, Rebecca G, Vainchenker, William, Adrian, Francisco, Villeval, Jean-Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627562/
https://www.ncbi.nlm.nih.gov/pubmed/26176817
http://dx.doi.org/10.1111/jcmm.12608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627562/
https://www.ncbi.nlm.nih.gov/pubmed/26176817
http://dx.doi.org/10.1111/jcmm.12608

Ejemplares similares